• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症疫苗的未来发展方向是什么。

What's next for cancer vaccines.

作者信息

Adamik Juraj, Butterfield Lisa H

机构信息

Parker Institute for Cancer Immunotherapy, University of California, San Francisco, Suite D3500, 1 Letterman Drive, San Francisco, CA 94129, USA.

出版信息

Sci Transl Med. 2022 Nov 9;14(670):eabo4632. doi: 10.1126/scitranslmed.abo4632.

DOI:10.1126/scitranslmed.abo4632
PMID:36350992
Abstract

Cancer vaccines have been shown clinically to drive tumor-reactive cell activation, proliferation, and effector function. Unfortunately, tumor eradication by treatment with cancer vaccines has been unsuccessful in many patients. Critical steps are under way to improve vaccine efficacy and combine them with immunotherapy and standard-of-care treatments.

摘要

癌症疫苗已在临床上显示出能驱动肿瘤反应性细胞的激活、增殖和效应功能。不幸的是,许多患者通过癌症疫苗治疗根除肿瘤的尝试均未成功。目前正在采取关键步骤来提高疫苗疗效,并将其与免疫疗法及标准治疗方法相结合。

相似文献

1
What's next for cancer vaccines.癌症疫苗的未来发展方向是什么。
Sci Transl Med. 2022 Nov 9;14(670):eabo4632. doi: 10.1126/scitranslmed.abo4632.
2
What's next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination.癌症免疫疗法的下一步是什么?—— 肿瘤新抗原疫苗的前景与挑战。
Oncoimmunology. 2022 Feb 13;11(1):2038403. doi: 10.1080/2162402X.2022.2038403. eCollection 2022.
3
Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.用于癌症免疫治疗的纳米级金属有机框架
Acc Chem Res. 2020 Sep 15;53(9):1739-1748. doi: 10.1021/acs.accounts.0c00313. Epub 2020 Aug 18.
4
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.DNA 疫苗攻击癌症:提高免疫原性和疗效的策略。
Pharmacol Ther. 2016 Sep;165:32-49. doi: 10.1016/j.pharmthera.2016.05.004. Epub 2016 May 24.
5
Cancer Vaccines.癌症疫苗。
Hematol Oncol Clin North Am. 2019 Apr;33(2):199-214. doi: 10.1016/j.hoc.2018.12.001. Epub 2019 Jan 28.
6
Mechanisms of T-cell inhibition: implications for cancer immunotherapy.T 细胞抑制的机制:对癌症免疫治疗的启示。
Expert Rev Vaccines. 2010 Jan;9(1):89-105. doi: 10.1586/erv.09.144.
7
IL-13 receptor-directed cancer vaccines and immunotherapy.白细胞介素-13 受体导向的癌症疫苗和免疫疗法。
Immunotherapy. 2012 Apr;4(4):443-51. doi: 10.2217/imt.12.28.
8
Taming cancer by inducing immunity via dendritic cells.通过树突状细胞诱导免疫来控制癌症。
Immunol Rev. 2007 Dec;220:129-50. doi: 10.1111/j.1600-065X.2007.00575.x.
9
Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach.将癌症疫苗与免疫疗法相结合:建立新的免疫学方法。
Int J Mol Sci. 2021 Jul 27;22(15):8035. doi: 10.3390/ijms22158035.
10
Therapeutic cancer vaccines: From initial findings to prospects.治疗性癌症疫苗:从初步发现到展望。
Immunol Lett. 2018 Apr;196:11-21. doi: 10.1016/j.imlet.2018.01.011. Epub 2018 Feb 4.

引用本文的文献

1
tumor cell engineering reverses immune escape to enhance immunotherapy effect.肿瘤细胞工程可逆转免疫逃逸以增强免疫治疗效果。
Acta Pharm Sin B. 2025 Jan;15(1):627-641. doi: 10.1016/j.apsb.2024.08.028. Epub 2024 Sep 2.
2
Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting.癌细胞的生存策略:巨吞饮作用在营养获取、代谢重编程及治疗靶点中的作用
Autophagy. 2025 Apr;21(4):693-718. doi: 10.1080/15548627.2025.2452149. Epub 2025 Jan 26.
3
Protecting Against Postsurgery Oral Cancer Recurrence with an Implantable Hydrogel Vaccine for In Situ Photoimmunotherapy.
使用可植入水凝胶疫苗进行原位光免疫疗法预防术后口腔癌复发
Adv Sci (Weinh). 2024 Dec;11(46):e2309053. doi: 10.1002/advs.202309053. Epub 2024 Oct 28.
4
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei.腹膜假性黏液瘤患者免疫微环境及免疫相关治疗的研究进展。
Cancer Biol Med. 2024 Jul 18;21(7):586-605. doi: 10.20892/j.issn.2095-3941.2024.0109.
5
Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.LRRC59 的泛癌症分析,重点是在肝细胞癌中的预后和免疫作用。
Aging (Albany NY). 2024 May 10;16(9):8171-8197. doi: 10.18632/aging.205810.
6
The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications.环状 RNA 在调节癌症免疫治疗耐药中的作用:机制与意义。
Cell Death Dis. 2024 May 2;15(5):312. doi: 10.1038/s41419-024-06698-3.
7
Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.用于癌症免疫治疗的免疫特异性和肿瘤依赖性mRNA疫苗:将临床转化重新编程为肿瘤编辑疗法。
Pharmaceutics. 2024 Mar 25;16(4):455. doi: 10.3390/pharmaceutics16040455.
8
Recent advances in nanoparticulate RNA delivery systems.纳米颗粒 RNA 递释系统的最新进展。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2307798120. doi: 10.1073/pnas.2307798120. Epub 2024 Mar 4.
9
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.没食子儿茶素没食子酸酯在肿瘤微环境、代谢重编程和免疫治疗中的作用。
Front Immunol. 2024 Jan 29;15:1331641. doi: 10.3389/fimmu.2024.1331641. eCollection 2024.
10
Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients.免疫代谢树突状细胞疫苗特征与接种黑色素瘤患者的总生存期相关。
Nat Commun. 2023 Nov 8;14(1):7211. doi: 10.1038/s41467-023-42881-4.